Our finding that IL-17 inhibition is most strongly associated with suppression of Klk1b22, a Kallikrein 1-related peptidase, is novel and may provide clues into the propagation of SS in salivary glands where IL-17-producing cells are resident. The gene discussed is IL17A; the disease is synovial sarcoma.